MedPath

Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment

Not Applicable
Completed
Conditions
Overactive Bladder Syndrome
Registration Number
NCT03250650
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

To evaluate the efficacy of combined transvaginal electrical stimulation (ES) and transcutaneous tibial nerve electrical stimulation (TTNS) in the treatment of female overactive bladder syndrome (OAB).

Detailed Description

This is a clinical trial, blind and randomized study with 86 women with OAB or Mixed Urinary Incontinence with prevalence in the OAB symptoms, who were randomly and allocated into 2 equal groups. Group 1 underwent transcutaneous tibial nerve electrical stimulation (TTNS),for 30 minutes using 10Hz for frequency and 200µs for pulse. Group 2 received a combined of Vaginal electrical stimulation (ES) using a transvaginal probe applied ,for 20 minutes using 10Hz for frequency and 1ms for pulse and tibial nerve electrical stimulation, 30 minutes at the same parameters used in Group1. Both groups were treated once a week for 12 sessions. All patients were evaluated before and after treatment by a voiding diary, King´s Health questionnaire, avaliation of pelvic floor muscle function, overactive bladder questionnaire (OABV-8).The analyzed variables included day and night time frequency, urgency and urge incontinence.

The sample calculation was based on the difference waited between 2 groups regarding the frequency improvment.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
86
Inclusion Criteria
  • Women diagnosed with Overactive Bladder Syndrom no neurogenic or Mixed Incontinence Urinary with overactive bladder´s predominance symptoms more than 6 months.
  • Over 18 years old.
  • Normal cognitive level to understand the orientations during the treatment.
Exclusion Criteria
  • Stress Urinary Incontinence
  • Drugs treatment for overactive bladder
  • Pregnant women
  • Neurologic diseases
  • Urinary infecction
  • Cystocele, rectocele and uterine prolapse
  • Infectious contagious diseases
  • Metal implants on the hip or lower members
  • Cardiac pacemaker
  • Bladder tumor
  • Vaginal infecction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Decreasing the numbers of urinary frequency during day and night1 month

We expect that patiens will decrease the void´s number during day (under 8), and during night, recovering theirs life´s quality.

Secondary Outcome Measures
NameTimeMethod
Improvement of miccional urgency and urinary urgency incontinence2 months

We expect that patients will get better decreasing symptoms of urinary urgency and urinary incontinence urgency consequently.

Trial Locations

Locations (1)

Universidade de São Paulo

🇧🇷

Sao Paulo, São Paulo, Brazil

Universidade de São Paulo
🇧🇷Sao Paulo, São Paulo, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.